Whalesbook
The Buyback Resurgence: Tax Reform and Capital Allocation Shift
Indian companies are shifting how they return capital to shareholders, increasingly choosing share buybacks instead of dividends. This change is largely driven by new tax efficiencies from Budget 2026, which make buybacks more attractive than dividends, especially after dividend taxes became less favorable. The Information Technology and Pharmaceutical sectors are leading this trend, thanks to their strong finances and steady free cash flow. The updated tax rules change the financial calculation for shareholders, moving from dividend tax rules to a more favorable tax on long-term capital gains. This shift is expected to significantly boost buyback activity in the next fiscal year.
IT and Pharma: Structural Advantages Fueling Buybacks
IT and Pharma companies have structural advantages that support ongoing buyback programs. These sectors consistently produce strong free cash flows and have low debt, giving them a stable base for deploying capital. Compared to industries needing heavy investment, their lower capital spending needs after initial phases mean more cash is available for shareholders. Buybacks offer two main benefits: they boost key financial metrics like Earnings Per Share (EPS) by reducing the number of shares, and they signal management's confidence in the company's value, especially if shares seem undervalued. Regular buybacks can lead to much higher EPS growth over time than dividend-only strategies.
Early Indicators and Sectoral Momentum
The expected increase in buybacks is already happening, with major IT and Pharma companies leading the way. Wipro has launched a large ₹15,000 crore buyback program, offering a premium to its current stock price. In the pharma sector, Aurobindo Pharma, Windlas Biotech, and Jagsonpal Pharma have announced significant repurchase plans, showing strong balance sheets and active capital management. These companies have ample cash reserves, reflecting a broader trend of record cash holdings among large Indian companies that highlights improved corporate financial strength. Analysts predict that substantial annual buybacks could significantly boost EPS growth for companies in major stock indexes.
The Regulatory Catalyst: Open Market Buybacks on the Horizon
A major potential boost for the buyback market comes from the Securities and Exchange Board of India (SEBI) looking into reintroducing open market buybacks. Currently, only tender-offer buybacks are allowed, which are less flexible and don't always match real market prices. If open market repurchases return, companies could buy shares over longer periods, matching purchases with market conditions and offering more transparency and chances for public investors to participate. This change could offer steadier support for stock prices compared to the one-off nature of tender offers, and better signal management's view on company valuation.
The Bear Case: Valuation Risks and Execution Challenges
Despite the good tax environment and strong cash flows, risks remain, especially regarding purchase prices. The main worry is that buying back shares when the market is high can actually harm shareholder value. Companies need to be very careful to ensure they buy shares only when they are genuinely undervalued. Also, a wider economic slowdown could reduce cash flow, limiting the size or length of buyback plans. Further regulatory changes by SEBI could also add restrictions. While IT and Pharma companies are financially strong, buying back shares too aggressively without considering true value can lead to wasted money. For example, TCS's buybacks are effective only if done at reasonable prices compared to its real worth. Likewise, HPCL's success depends on buying shares at good times, not just buying them continuously.